Institut Catala D'oncologia — Clinical Trial Site

924 Registered trials

494 Currently recruiting

Organisation

Institut Catala D'oncologia

Location

L'hospitalet De Llobregat, Spain

Identifier

ORG-100030394

Address

Carretera Canyet S/n, 08916, Spain

Departments

-
#1301: Oncologia
#1402: Oncología
#2001:Oncology
#2031:Hematology
#2455: Oncologia
#2900:Hematología Clínica
#3904; Hematología Clínica
#4007:Hematología Clínica
#4009:Hematología Clínica
#6000:Oncología
#6003: Servicio Oncología
#7000: Hematología
#752; Oncologia
#9007: Oncology
#93158006: Oncología Médica
#98358006: Oncology
#E3032401: N/A
034036: Oncología Médica
1211:Oncología Médica
1304: Hematología
1321: Hematologia
1501 Oncología
1600 Oncology
172406: Hematología
172411: Hematologia
1803: Hematología
2101: Department Oncology
2201: Oncologia
2909: Hematology
2911: Hematology
3003:Servicio de Oncologia
3203: Hematologia
3211: Hematologia
34005: Oncologia
34009: Oncologia
34013: Oncología Médica
3404: Servicio de Hematologia
3603; Oncología Médica
4502:Servicio Oncología
6001:Oncologia Médica
609 : Oncología Médica
7001: Oncologia
7001: Oncology
7002: Oncologia
7003: Oncología Médica
7004: Oncología Médica
7005: Oncología Médica
7006: Oncologia
7007: Oncología Médica
7008: Oncologia
7010: Oncología Médica
7113:Oncología
724002; Hematología
724002: Hematología
724013: Oncologia
724023: Oncología Médica
743: Hematologia
arly Drug Development Group - Medical Oncology Department
Cancer Epidemiology Research Programme PREC
Clinic Hematology
Clinical Haematology
Clinical Haematology Service
Clinical Haematology Service/ Servicio de hematología clínica
Clinical Hematology
Clinical Hematology department
Clinical Hematology Service
Clinical research department
Clinical research unit
Departamento de Oncología Médica
Department de Hematology Clinical
Department of Clinical Hematology
Department of Hematology
Department of Medical Oncology
Department of Oncology
Division of Medical Oncology, Head and Neck Cancer Unit H. Duran i Reynals
Edificio de Consultas Externas, 2ª planta, Servicio de Oncología Médica
Ensayos Clinicos Oncologia
ES001A: Hematología
ES10004: Hematología
ES10006: Hematología y Hemoterapia
ES10008: Hematología
ES10013: Hematología
ES30007: Hematología
ES30008:Hematología y Hemoterapia
ESP003: Hematologia
ESP03-0: Oncologia Médica
ESP05-0: Oncologia Médica
Gastroenterology Department
Genetic Counseling Unit
Genitourinary Cancer Unit
Haematology
Haematology Department
Hemarología
Hematolgy
Hematologia
Hematologia clinica
Hematologist
hematology
Hematology and hematherapy
Hematology and Hemotherapy Service
Hematology Department
Hematology Department and Hematopoietic Stem Cell Transplant Programme
Hematology Department Lymphoma Unit
Hematology sercive
Hematology service
Hematology Unit
Hematology/Oncology
Hematopoietic Cell Transplant and Cell Therapy Unit
Hemtaology
Hospital Universitario Dr. Josep Trueta; Medical Oncology
ICO L'Hospitalet (Hospital Duran i Reynals)
Infectious Diseases Unit
Institut Català d' Oncologia
Institut Català d'oncologia
Institut Català d'Oncologia - Institut de Recerca Josep Carreras
Lymphoma Unit
Maternal
Medical Hematology
Medical Oncologist
Medical Oncology
Medical Oncology Department
Medical Oncology Departmnent
Medical Oncology Service
Medicine
N/A
NA
Onccology
Oncolgy
Oncolgy Service
Oncología
Oncología Médica
Oncologia Mèdica / Medical Oncology Department
Oncología Radioterápica
Oncología, 503
Oncology
Oncology Department
Oncology Medical
Oncology service
Oncology Service Department
Ophthalmology
ospital de Girona Dr. Josep Trueta
Phase 1 Unit. Breast Cancer Unit
Planta 4. ICO de Badalona. Ensayos Clinicos
Radiation Oncology
Radiotherapy Oncology
Radiotherapy oncology service
Sáez
Servicio de Hematologia
Servicio de Hematologia Clinica
Servicio de Oncología
Servicio de Oncologia Medica
Servicio de Oncología Médica - Area Ensayos Clínicos
Servicio Oncologia
Servicio Oncologia Medica
Thoracic Oncology
Trucco
ukn
Unidad de Ensayos Clinicos de Oncologia
Unidad de Fase 1
Unidad de Investigación Clínica
Unidad de Sarcoma y Cáncer Genitourinario
Unitat Funcional Fase 1
Z97ES10008: Hematología
Z97ES10011: Hematologia

Clinical trials at this site (924)

Search interface

Ribociclib in combination with endocrine therapy in patients with “estrogen receptor-positive and HER2-negative” breast cancer with high ris… Ended

2023-508827-10-00 Patients with primary operable stage II, grade 2 or 3, 4 2025-10-13
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Gastroesophageal Junction Adenocarcinoma 5 2025-07-31
Phase 1b/2 Study of Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Participants With Advanced Gastric Cancer (Substudy GC) Ended

2024-517817-34-00 Gastric Cancer 9 2025-06-18
PLUG-IN. Phase 2 of pembrolizumab combined with enfortumab vedotin for advanced melanoma patients. Ended

2024-514163-26-00 Advanced Melanoma 4 2025-06-09
Phase 1b/2 Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced NSCLC (Substudy NSCLC) Ended

2024-517818-15-00 Non-Small Cell Lung Cancer 9 2025-06-06
"Neoadjuvant phase II study of pembrolizumab and carboplatin plus paclitaxel for stage I triple-negative breast cancer (The TELESCOPE study)… Ended

2024-513511-27-00 HR-negative/HER2-negative resectable stage I TNBC. 4 2025-05-29
A study to test different doses of BI 1831169 alone and in combination with an anti-PD-1 antibody in people with different types of advanced… Ended

2024-512504-19-00 solid tumors 1 2025-05-28
Dose escalation/expansion trial with BYON4228 alone and in combination in metastatic solid tumors Ended

2024-517952-37-00 Locally advanced or metastatic cancer (Solid tumors) 9 2025-05-22
First trial in humans testing the safety and efficacy of IMGN151 in women with recurrent gynaecological cancers Ended

2023-506842-22-00 Recurrent endometrial cancer, recurrent epithelial ovar 7 2025-05-19
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, … Ended

2024-512925-95-00 Advanced/Metastatic Breast Cancer 5 2025-05-16
A study of the PAN-KRAS inhibitor LY4066434 in participants with KRAS mutant solid tumors. Ended

2024-516733-12-00 Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung C 1 2025-05-13
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Progressive Metastatic Castration-… Ended

2024-513968-25-00 Metastatic castration-resistant prostate cancer (mCRPC) 5 2025-04-28
A Phase I/IIa Study of Roginolisib in combination with dostarlimab with or without docetaxel in Advanced NSCLC (PULMO-01) Ended

2024-517741-14-00 advanced non-squamous non-small cell lung cancer (NSCLC 9 2025-04-22
Study to test new drug eftilagimod alfa (also known as efti) combined with standard marketed treatments (pembrolizumab and chemotherapy) in … Ended

2024-513621-23-00 Advanced/metastatic non-small cell lung cancer (NSCLC) 5 2025-04-18
A clinical study of pembrolizumab and other treatments for non-small cell lung cancer (MK-3475-01G) Ended

2024-515772-12-00 Lung neoplasm malignant (Stage IV Non-small cell lung c 4 2025-04-18
A Multicenter, Open-Label, Single-Arm, Phase II Trial Exploring the Maintenance of Trastuzumab and Pertuzumab Following Trastuzumab Deruxtec… Ended

2023-507306-13-00 HER2-positive unresectable locally recurrent or metasta 4 2025-04-13
A clinical study of raludotatug deruxtecan in people with gastrointestinal cancers (MK-5909-005) Ended

2024-517416-30-00 Gastrointestinal Cancers 10 2025-03-31
Phase 2/3 Randomized Study of INBRX-106 Add-on to Pembrolizumab in First-Line PD-L1 CPS ≥20 R/M HNSCC (HexAgon-HN) Ended

2024-515538-34-00 Head and Neck Squamous Cell Carcinoma 10 2025-02-27
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer Ended

2024-512998-27-00 Non-Small Cell Lung Cancer 5 2025-02-21
A study to test an oral medicine, belumosudil, in combination with corticosteroids in participants at least 12 years of age with newly diagn… Ended

2023-505394-32-00 chronic graft versus host disease 5 2025-02-06
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women with Breast Cancer Who Are Having Hormone Therapy Ended

2024-510719-31-00 Moderate to Severe Vasomotor Symptoms (VMS) 5 2025-01-24
A Study to Learn About the Investigational Medicine Called PF-06821497 (mevrometostat) in Men with mCRPC Who Were Previously Treated with Ab… Ended

2024-511650-50-00 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 5 2025-01-17
An open label, single-arm, phase 2 study of perioperative sacituzumab govitecan in combination with zimberelimab and domvanalimab for patien… Ended

2023-504420-26-00 Bladder Cancer 4 2025-01-13
Research study on the use of capivasertib together with fulvestrant in patients with advanced breast cancer who have relapsed/progressed to … Ended

2024-513952-13-00 HR+ / HER2- advanced breast cancer 5 2025-01-02